15P - ATM loss in NSCLC increases sensitivity to cisplatin and PARP inhibition

Autor: Bebb, D.G., Petersen, L.F., Moore, J., Elegbede, A., Lees-Miller, S.
Zdroj: In Annals of Oncology February 2019 30 Supplement 1:i6-i6
Databáze: ScienceDirect